Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$7.48 - $10.7 $14,212 - $20,330
1,900 New
1,900 $19,000
Q4 2022

Feb 07, 2023

SELL
$7.95 - $9.48 $115,052 - $137,194
-14,472 Reduced 46.89%
16,395 $149,000
Q3 2022

Oct 25, 2022

SELL
$6.86 - $11.95 $46,689 - $81,331
-6,806 Reduced 18.07%
30,867 $249,000
Q2 2022

Aug 04, 2022

BUY
$7.38 - $10.4 $37,018 - $52,166
5,016 Added 15.36%
37,673 $283,000
Q1 2022

Apr 14, 2022

BUY
$7.33 - $9.39 $204,924 - $262,516
27,957 Added 594.83%
32,657 $306,000
Q4 2021

Jan 18, 2022

BUY
$7.9 - $10.19 $37,130 - $47,893
4,700 New
4,700 $37,000
Q1 2021

Apr 26, 2021

SELL
$10.34 - $12.81 $154,066 - $190,869
-14,900 Closed
0 $0
Q4 2020

Jan 21, 2021

SELL
$8.61 - $11.04 $32,098 - $41,157
-3,728 Reduced 20.01%
14,900 $143,000
Q2 2020

Jul 22, 2020

SELL
$8.12 - $13.12 $38,975 - $62,975
-4,800 Reduced 20.49%
18,628 $229,000
Q1 2020

May 07, 2020

BUY
$6.69 - $13.45 $51,593 - $103,726
7,712 Added 49.07%
23,428 $210,000
Q4 2019

Feb 06, 2020

BUY
$6.53 - $10.72 $38,527 - $63,248
5,900 Added 60.11%
15,716 $154,000
Q3 2019

Oct 28, 2019

SELL
$6.16 - $9.6 $27,313 - $42,566
-4,434 Reduced 31.12%
9,816 $67,000
Q2 2019

Aug 09, 2019

BUY
$8.12 - $15.72 $114,621 - $221,903
14,116 Added 10534.33%
14,250 $131,000
Q1 2019

May 10, 2019

SELL
$15.58 - $20.01 $48,298 - $62,031
-3,100 Reduced 95.86%
134 $2,000
Q3 2018

Nov 07, 2018

BUY
$21.06 - $25.65 $12,636 - $15,390
600 Added 22.78%
3,234 $69,000
Q2 2018

Aug 10, 2018

SELL
$16.77 - $24.71 $56,447 - $83,173
-3,366 Reduced 56.1%
2,634 $64,000
Q1 2018

May 11, 2018

BUY
$16.68 - $22.07 $76,160 - $100,771
4,566 Added 318.41%
6,000 $102,000
Q4 2017

Jan 17, 2018

SELL
$11.23 - $19.1 $420,833 - $715,753
-37,474 Reduced 96.31%
1,434 $27,000
Q3 2017

Oct 17, 2017

BUY
$15.41 - $32.17 $599,572 - $1.25 Million
38,908
38,908 $684,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.